Vora, D.; Dandekar, A.; Bhattaccharjee, S.; Singh, O.N.; Agrahari, V.; Peet, M.M.; Doncel, G.F.; Banga, A.K.
Formulation Development for Transdermal Delivery of Raloxifene, a Chemoprophylactic Agent against Breast Cancer. Pharmaceutics 2022, 14, 680.
https://doi.org/10.3390/pharmaceutics14030680
AMA Style
Vora D, Dandekar A, Bhattaccharjee S, Singh ON, Agrahari V, Peet MM, Doncel GF, Banga AK.
Formulation Development for Transdermal Delivery of Raloxifene, a Chemoprophylactic Agent against Breast Cancer. Pharmaceutics. 2022; 14(3):680.
https://doi.org/10.3390/pharmaceutics14030680
Chicago/Turabian Style
Vora, Deepal, Amruta Dandekar, Sonalika Bhattaccharjee, Onkar N. Singh, Vivek Agrahari, M. Melissa Peet, Gustavo F. Doncel, and Ajay K. Banga.
2022. "Formulation Development for Transdermal Delivery of Raloxifene, a Chemoprophylactic Agent against Breast Cancer" Pharmaceutics 14, no. 3: 680.
https://doi.org/10.3390/pharmaceutics14030680
APA Style
Vora, D., Dandekar, A., Bhattaccharjee, S., Singh, O. N., Agrahari, V., Peet, M. M., Doncel, G. F., & Banga, A. K.
(2022). Formulation Development for Transdermal Delivery of Raloxifene, a Chemoprophylactic Agent against Breast Cancer. Pharmaceutics, 14(3), 680.
https://doi.org/10.3390/pharmaceutics14030680
